Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Feasibility Study: Sleuth Monitoring System (PULSE)
This study is ongoing, but not recruiting participants.
Sponsored by: Transoma Medical
Information provided by: Transoma Medical
ClinicalTrials.gov Identifier: NCT00719277
  Purpose

The purpose of the study is to evaluate the safety and performance of the Sleuth Monitoring system.


Condition Intervention
Arrhythmia
Syncope
Device: Sleuth Implantable ECG Monitoring System

Genetics Home Reference related topics: Brugada syndrome short QT syndrome
MedlinePlus related topics: Arrhythmia Fainting
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Open Label, Single Group Assignment
Official Title: Pilot Clinical Study of the Sleuth Implantable ECG Monitoring System

Further study details as provided by Transoma Medical:

Primary Outcome Measures:
  • Diagnostically viable ECG signals [ Time Frame: daily ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • rate of device-related adverse events [ Time Frame: 1, 6, and 12 months ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 40
Study Start Date: December 2006
Estimated Study Completion Date: September 2009
Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Sleuth Implantable ECG Monitoring System
    The study device provides monitoring only. It cannot provide intervention or treatment.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age > = 18 years at time of enrollment
  • Either of the following:

    1. MI > 30 days prior to enrolment and LVEF < = 35% by echocardiography (or nuclear imaging as necessary)
    2. Syncope of unknown etiology

Exclusion Criteria:

  • Life expectancy < 12 months following enrollment
  • Active infection
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00719277

Locations
Panama
Hospital Paitilla
Panama city, Panama
Sponsors and Collaborators
Transoma Medical
Investigators
Study Director: Dennis Crane Transoma Medical
  More Information

Sponsor website  This link exits the ClinicalTrials.gov site

Responsible Party: Transoma Medical ( VP Clinical Affairs )
Study ID Numbers: CLP-005
Study First Received: July 17, 2008
Last Updated: July 17, 2008
ClinicalTrials.gov Identifier: NCT00719277  
Health Authority: Panama: Ministry of Health

Keywords provided by Transoma Medical:
cardiac arrhythmia
syncope
ECG
implantable ECG monitor
ILR

Study placed in the following topic categories:
Signs and Symptoms
Unconsciousness
Heart Diseases
Consciousness Disorders
Neurologic Manifestations
Neurobehavioral Manifestations
Syncope
Arrhythmias, Cardiac

Additional relevant MeSH terms:
Pathologic Processes
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 13, 2009